Literature DB >> 15070235

Spastic/spasmodic vs. tremulous vocal quality: motor speech profile analysis.

Donna S Lundy1, Soham Roy, Jun W Xue, Roy R Casiano, Daniel Jassir.   

Abstract

Strained, strangled, and tremulous vocal qualities that are typically seen in adductor spasmodic dysphonia (ADSD), voice tremor (Tremor), and the spastic dysarthria of amyotrophic lateral sclerosis (ALS) may sound similar and be difficult to differentiate. The purpose of this study was to determine if these vocal qualities of neurologic origin could be differentiated on the basis of acoustic and motor speech parameters. Three groups of subjects (ADSD, ALS, and Tremor) were analyzed by the Motor Speech Profile System (Kay Elemetrics, Lincoln Park, NJ) for fundamental frequency (Fo), standard deviation of Fo, diadochokinetic rate (ddk), standard deviation of ddk, mean intensity and standard deviation of ddk, frequency and amplitude variability in connected speech, and speaking rate in connected speech. Profiles of the three groups are presented with the significant features that differentiated one from the other.

Entities:  

Mesh:

Year:  2004        PMID: 15070235     DOI: 10.1016/j.jvoice.2003.12.001

Source DB:  PubMed          Journal:  J Voice        ISSN: 0892-1997            Impact factor:   2.009


  3 in total

1.  Analysis of diadochokinesis in ataxic dysarthria using the motor speech profile program.

Authors:  Yu-Tsai Wang; Ray D Kent; Joseph R Duffy; Jack E Thomas
Journal:  Folia Phoniatr Logop       Date:  2008-12-17       Impact factor: 0.849

Review 2.  Speech-Language Pathology Evaluation and Management of Hyperkinetic Disorders Affecting Speech and Swallowing Function.

Authors:  Julie M Barkmeier-Kraemer; Heather M Clark
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2017-09-21

3.  Objectively Monitoring Amyotrophic Lateral Sclerosis Patient Symptoms During Clinical Trials With Sensors: Observational Study.

Authors:  Luis Garcia-Gancedo; Madeline L Kelly; Arseniy Lavrov; Jim Parr; Rob Hart; Rachael Marsden; Martin R Turner; Kevin Talbot; Theresa Chiwera; Christopher E Shaw; Ammar Al-Chalabi
Journal:  JMIR Mhealth Uhealth       Date:  2019-12-20       Impact factor: 4.773

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.